KL

Kiran Lachmandas Lund

Active Director Director DIN 07602732
DIN 07602732 First appointment Sep 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2016
Shareholding value •••• Premium profile

About Kiran Lachmandas Lund

Data last updated:

Kiran Lachmandas Lund is a Director at Biotime Pharmaceuticals Private Limited (since 2016). The company operates in Pharma. Biotime Pharmaceuticals Private Limited reported revenue of ₹10.93 Cr (FY 2025).

DIN 07602732
Primary Designation Director
Industry Pharma
First Appointment 15 Sep 2016
Oldest Company Age 10 yrs
Largest company Biotime Pharmaceuticals Private Limited · ₹10.93 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Sep 20162016₹10.93 Cr (FY 2025)Active

Board colleagues of Kiran Lachmandas Lund

Directorship timeline

Open interactive timeline →
Biotime Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kiran Lachmandas Lund

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kiran Lachmandas Lund

Kiran Lachmandas Lund currently holds 1 directorship: Biotime Pharmaceuticals Private Limited (Director, since 15 Sep 2016, revenue ₹10.93 Cr (FY 2025)).

Kiran Lachmandas Lund was first appointed on 15 Sep 2016 as Director at Biotime Pharmaceuticals Private Limited.

The current boards of Kiran Lachmandas Lund's companies include Lachmandas Gelaram Lund (Biotime Pharmaceuticals Private Limited), Nitesh Lachman Lund (Biotime Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available